Research output per year
Research output per year
Search results
-
2018
Treatment escalation in patients with early stage Hodgkin lymphoma and a positive PET scan after initial chemotherapy is not always required: subsidiary analysis of the UK NCRI RAPID study
Barrington, S., Phillips, E. H., Counsell, N., Hancock, B., Pettengell, R., Johnson, P., Wimperis, J., Culligan, D., Popova, B., Clifton-Hadley, L., McMillan, A., Brownell, A., Kruger, A., Lister, A., Hoskin, P., O'Doherty, M., Illidge, T. & Radford, J., Apr 2018, In: British Journal of Haematology. 181, p. 24-24Research output: Contribution to journal › Meeting Abstract › peer-review
-
2017
Results of a phase II study of brentuximab vedotin in the first line treatment of Hodgkin lymphoma patients considered unsuitable for standard chemotherapy (BREVITY)
Gibb, A., Pirrie, S., Linton, K., Paterson, K., Davies, A., Collins, G., Menne, T., McKay, P., Fields, P., Miall, F., Nagy, E., Wheatley, K., Warbey, V., Barrington, S. & Radford, J., 7 Jun 2017, In: Hematological oncology. 35, S1, p. 80-81 2 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Open AccessFile52 Downloads (Pure) -
2007
Organisation of national central review of FDG-PET imaging in a UK randomised trial in early stage Hodgkin lymphoma
Barrington, S. F., O'Doherty, M. J., Mackewn, J., Schleyer, P., Mouncey, P., Qian, W., Illidge, T., Hoskin, P., Pettengell, R., Hancock, B. W. & Radford, J. A., 2007, In: Haematologica. 92, 5, p. 72-72 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review